Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 11—November 2026

Research

Five-Biomarker Definition for Hypervirulent Klebsiella pneumoniae Bloodstream Infection and Abscess Complications, Japan, 2022–2024

Naoki WatanabeComments to Author , Tomohisa Watari, Yoshihito Otsuka, and Tomoh Matsumiya
Author affiliation: Hirosaki University Graduate School of Health Sciences, Hirosaki, Japan (N. Watanabe, T. Matsumiya); Kameda Medical Center, Kamogawa, Japan (T. Watari, Y. Otsuka)

Main Article

Table 1

Baseline characteristics of 207 patients with hypervirulent and classical Klebsiella pneumoniae bloodstream infections in a study of five-biomarker definition for hvKp, Japan, 2022–2024*

Characteristics hvKp, n = 28 cKp, n = 179 p value†
Demographic characteristics
Median age, y (IQR) 76 (71–81) 78 (69–85)   0.64
Sex
M 21 (75) 108 (60)   0.15
F 7 (25) 71 (40)
Median body mass index (IQR), n = 201
21 (20–23)
20 (18–24)
  0.65
Underlying conditions
Median CCI score (IQR) 2 (1–4)   3 (2–5)   0.15
Diabetes, any 9 (32) 62 (35) >0.99
Chronic kidney disease 3 (11) 23 (13) >0.99
Liver disease 1 (4)   9 (5) >0.99
Solid tumor
8 (29)
64 (36)
  0.53
Healthcare exposure
Indwelling device 12 (43) 114 (64)   0.04
Recent hospitalization 12 (43) 112 (63)   0.06
Prior antibiotic exposure
9 (32)
99 (55)
  0.02
Infection characteristics
Onset classification   0.30
Healthcare-associated 15 (54) 114 (64)
Community-acquired
13 (46)
65 (36)

Primary source of infection   0.03
Urinary tract 7 (25) 37 (21)
Catheter-related 0 (0.0)   5 (3)
Intraabdominal 13 (46) 83 (46)
Respiratory 4 (14)   5 (3)
Other 1 (4)   1 (<1)
Unknown
3 (11)
48 (27)

Microbiological characteristics
Multidrug resistance 3 (11) 53 (30)   0.04
Polymicrobial bloodstream infection 3 (11) 42 (23)   0.15

*Values are no. (%) except as indicated. CCI, Charlson comorbidity index; cKp, classical K. pneumoniae; hvKp, hypervirulent K. pneumoniae; IQR, interquartile range. †p values were calculated using Fisher exact test for categorical variables and Mann–Whitney U test for continuous variables and were provided for descriptive purposes.

Main Article

Page created: September 16, 2026
Page updated: October 14, 2026
Page reviewed: October 14, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external